ClinicalTrials.Veeva

Menu

Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry (PRIISM2)

M

MindFrame

Status

Unknown

Conditions

Ischemic Stroke

Treatments

Procedure: Mechanical thrombectomy

Study type

Observational

Funder types

Industry

Identifiers

NCT01560247
EU-PRIISM-02

Details and patient eligibility

About

To determine the revascularization rate, clinical efficacy and safety of the CE-marked MindFrame System in ischemic stroke patients

Full description

To determine the revascularization rate, clinical efficacy and safety in a "real-world setting" of the CE-marked MindFrame System in ischemic stroke patients with thrombotic neurovascular occlusions caused by an embolus deemed appropriate for endovascular treatment. Target vessels include the basilar, internal carotid and middle cerebral (M1 and M2 segments) arteries.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of ischemic stroke for whom the physician has prescribed mechanical thrombectomy as appropriate therapy

Exclusion criteria

  • Intracranial hemorrhage

Trial design

1,000 participants in 1 patient group

Treatment Group
Description:
Subjects in whom a MindFrame Device was employed for restoration of flow and clot removal
Treatment:
Procedure: Mechanical thrombectomy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems